Patent Assignment
Reel/Frame 007835/0776
Assignment of Assignor's Interest
Recorded: 1996-03-11
Pages: 7
Assignors
DIJKE, PETER TEN
Executed: 1995-08-15
HELDIN, CARL-HENRIK
Executed: 1995-08-15
MIYAZONO, KOHEI
Executed: 1995-08-16
Assignee
LUDWIG INSTITUTE FOR CANCER RESEARCH
1345 AVENUE OF THE AMERICAS, NEW YORK, NEW YORK, 10105
Covered Property
(1)
Methods of Antagonizing Op-1 Binding to Cell Surface Receptor Utilizing Alk Polypeptides
Patent:
5,863,738 →
Application:
08/481,337 →
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 11, 1996
From: SAMPATH, KUBER
To: CREATIVE BIOMOLECULES, INC.
Reel/Frame 007837/0725 →
Assignment of Assignor's Interest
May 23, 1996
From: SAMPATH, KUBER T.
To: CREATIVE BIOMOLECULES, INC.
Reel/Frame 007951/0337 →
Assignment of Assignor's Interest
Nov 19, 1996
From: TEN DIJKE, PETER; HELDIN, CARL-HENRIK; MIYAZONO, KOHEI
To: LUDWIG INSTITUTE FOR CANCER RESEARCH A SWISS NOT-FOR-PROFIT CORPORATION
Reel/Frame 008234/0088 →
Merger
Jul 16, 2003
From: CREATIVE BIOMOLECULES, INC.; ONTOGENY, INC.; REPROGENESIS, INC.
To: CURIS, INC.
Reel/Frame 013798/0552 →
Assignment of Assignor's Interest
Sep 5, 2008
From: CURIS, INC.
To: STRYKER CORPORATION
Reel/Frame 021489/0045 →
Assignment of Assignor's Interest
Aug 14, 2014
From: STRYKER CORPORATION
To: MARIEL THERAPEUTICS, INC.
Reel/Frame 033535/0440 →
Assignment of Assignor's Interest
Jan 8, 2016
From: STRYKER CORPORATION
To: MARIEL THERAPEUTICS, INC.
Reel/Frame 037460/0806 →
Lien
Jan 8, 2016
From: STRYKER CORPORATION
To: MARIEL THERAPEUTICS, INC.
Reel/Frame 037461/0778 →